O'Keefe RJ - Search Results

1

TNF-alpha and pathologic bone resorption.

Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, O'Keefe RJ, Xing L. Boyce BF, et al. Keio J Med. 2005 Sep;54(3):127-31. doi: 10.2302/kjm.54.127. Keio J Med. 2005. PMID: 16237274 Free article. Review.

2

Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.

Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, Ritchlin CT, Boyce BF, Xing L. Li P, et al. Arthritis Rheum. 2004 Jan;50(1):265-76. doi: 10.1002/art.11419. Arthritis Rheum. 2004. PMID: 14730625 Free article.

3

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L. Li P, et al. J Bone Miner Res. 2004 Feb;19(2):207-13. doi: 10.1359/JBMR.0301233. J Bone Miner Res. 2004. PMID: 14969390 Free article.

4

Autoimmunity and bone.

Schwarz EM, Looney RJ, Drissi MH, O'Keefe RJ, Boyce BF, Xing L, Ritchlin CT. Schwarz EM, et al. Ann N Y Acad Sci. 2006 Apr;1068:275-83. doi: 10.1196/annals.1346.031. Ann N Y Acad Sci. 2006. PMID: 16831928

5

Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.

Usui M, Xing L, Drissi H, Zuscik M, O'Keefe R, Chen D, Boyce BF. Usui M, et al. J Bone Miner Res. 2008 Mar;23(3):314-25. doi: 10.1359/jbmr.071025. J Bone Miner Res. 2008. PMID: 17967138 Free PMC article.

6

In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.

Childs LM, Paschalis EP, Xing L, Dougall WC, Anderson D, Boskey AL, Puzas JE, Rosier RN, O'Keefe RJ, Boyce BF, Schwarz EM. Childs LM, et al. J Bone Miner Res. 2002 Feb;17(2):192-9. doi: 10.1359/jbmr.2002.17.2.192. J Bone Miner Res. 2002. PMID: 11811549 Free article.

7

Immunohistochemical study of receptor activator of nuclear factor kappa-B ligand (RANK-L) in human osteolytic bone tumors.

Good CR, O'Keefe RJ, Puzas JE, Schwarz EM, Rosier RN. Good CR, et al. J Surg Oncol. 2002 Mar;79(3):174-9. doi: 10.1002/jso.10067. J Surg Oncol. 2002. PMID: 11870668

8

Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.

Goater JJ, O'Keefe RJ, Rosier RN, Puzas JE, Schwarz EM. Goater JJ, et al. J Orthop Res. 2002 Mar;20(2):169-73. doi: 10.1016/S0736-0266(01)00083-3. J Orthop Res. 2002. PMID: 11918293 Free article.

9

Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.

Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ. Carmody EE, et al. Arthritis Rheum. 2002 May;46(5):1298-308. doi: 10.1002/art.10227. Arthritis Rheum. 2002. PMID: 12115237 Free article.

10

The role of p105 protein in NFkappaB activation in ANA-1 murine macrophages following stimulation with titanium particles.

Soloviev A, Schwarz EM, Kuprash DV, Nedospasov SA, Puzas JE, Rosier RN, O'Keefe RJ. Soloviev A, et al. J Orthop Res. 2002 Jul;20(4):714-22. doi: 10.1016/S0736-0266(01)00180-2. J Orthop Res. 2002. PMID: 12168659 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page